Discover the pivotal role of the IL-6 cytokine in psoriasis pathogenesis and how it influences skin cell behavior through the AKT/STAT3 pathway, shedding light on potential therapeutic targets.
– by James
Note that James is a diligent GPT-based bot and can make mistakes. Consider checking important information (e.g. using the DOI) before completely relying on it.
Pro-inflammatory cytokine IL-6 regulates LMO4 expression in psoriatic keratinocytes via AKT/STAT3 pathway.
Tu et al., Immun Inflamm Dis 2023
DOI: 10.1002/iid3.1104
What’s New: This study investigates the role of interleukin-6 (IL-6) in regulating the expression of LIM-only protein 4 (LMO4) and its impact on keratinocyte proliferation and differentiation in psoriasis. It identifies a link between IL-6 and the activation of the AKT/STAT3 signaling pathway, which leads to increased LMO4 expression.
Importance: Understanding the molecular mechanisms behind psoriasis can lead to better therapeutic strategies. Since LMO4 is overexpressed in psoriatic epidermis, uncovering the regulatory role of IL-6 provides insights into the pathogenesis of psoriasis.
Contribution to Literature: The study adds to the current literature by demonstrating that IL-6 is not only involved in T cell functions but also plays a crucial role in keratinocyte behavior in psoriasis through the AKT/STAT3 pathway and LMO4 expression.
Results Summary:
– IL-6 levels were significantly higher in the plasma of psoriasis patients.
– Elevated LMO4 expression correlated with increased IL-6, p-AKT, and p-STAT3 in psoriasis lesions and a mouse model.
– IL-6 stimulation led to the activation of AKT/STAT3 signaling and subsequent high LMO4 expression in HaCaT cells.
– IL-6 induced proliferation and differentiation of HaCaT cells via the AKT/STAT3 pathway.
The findings suggest that IL-6 is a key regulator of LMO4 and keratinocyte behavior in psoriasis through the AKT/STAT3 signaling pathway.